<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">ARYA Atheroscler</journal-id><journal-id journal-id-type="iso-abbrev">ARYA Atheroscler</journal-id><journal-id journal-id-type="publisher-id">ARYA</journal-id><journal-title-group><journal-title>ARYA Atherosclerosis</journal-title></journal-title-group><issn pub-type="ppub">1735-3955</issn><issn pub-type="epub">2251-6638</issn><publisher><publisher-name>Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23696754</article-id><article-id pub-id-type="pmc">3653269</article-id><article-id pub-id-type="publisher-id">ARYA-09-11</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The incidence of in-hospital atrial fibrillation after coronary artery bypass grafting using ventricular and atrial pacing</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Naghnaeian</surname><given-names>Mina</given-names></name><xref ref-type="aff" rid="af1-ARYA-09-11">1</xref><xref rid="c1-ARYA-09-11" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Samienasab</surname><given-names>Mohammadreza</given-names></name><xref ref-type="aff" rid="af2-ARYA-09-11">2</xref></contrib><contrib contrib-type="author"><name><surname>Mirmohammadsadeghi</surname><given-names>Mohsen</given-names></name><xref ref-type="aff" rid="af3-ARYA-09-11">3</xref></contrib><contrib contrib-type="author"><name><surname>Rabani</surname><given-names>Majid</given-names></name><xref ref-type="aff" rid="af1-ARYA-09-11">1</xref></contrib><contrib contrib-type="author"><name><surname>Pourmoghaddas</surname><given-names>Ali</given-names></name><xref ref-type="aff" rid="af4-ARYA-09-11">4</xref></contrib><contrib contrib-type="author"><name><surname>Behnemun</surname><given-names>Mahsa</given-names></name><xref ref-type="aff" rid="af1-ARYA-09-11">1</xref></contrib></contrib-group><aff id="af1-ARYA-09-11"><label>1</label>Resident, Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran</aff><aff id="af2-ARYA-09-11"><label>2</label>Associate Professor, Department of Cardiology, Isfahan University of Medical Sciences, Isfahan, Iran</aff><aff id="af3-ARYA-09-11"><label>3</label>Associate Professor, Department of Cardiac Surgery, Isfahan University of Medical Sciences, Isfahan, Iran</aff><aff id="af4-ARYA-09-11"><label>4</label>Associate Professor, Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran</aff><author-notes><corresp id="c1-ARYA-09-11">Correspondence to: Mina Naghnaeian, Email: <email xlink:href="lacrimal_lake2004@yahoo.com">lacrimal_lake2004@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2013</year></pub-date><volume>9</volume><issue>1</issue><fpage>11</fpage><lpage>15</lpage><history><date date-type="received"><day>02</day><month>11</month><year>2012</year></date><date date-type="accepted"><day>09</day><month>1</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9; 2013 Isfahan Cardiovascular Research Center &#x00026; Isfahan University of Medical Sciences</copyright-statement><copyright-year>2013</copyright-year><license xlink:href="http://creativecommons.org/licenses/by-nc/3.0/" license-type="open-access"><license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</license-p></license></permissions><abstract><sec id="st1"><title>BACKGROUND</title><p>Atrial fibrillation (AF) after coronary artery bypass graft (CABG) surgery is a common problem. In this study, we sought to evaluate the safety and tolerance of continuous atrial pacing after CABG. We hypothesized that a strategy of temporary atrial pacing after CABG would reduce the incidence of postoperative AF.</p></sec><sec id="st2"><title>METHODS</title><p>During 2012, CABG candidates over 18 years of age at Sina Hospital (Isfahan, Iran) were recruited. Before surgery, the participants were randomly assigned to two groups of ventricular pacing and left atrial ventricular pacing (atrial pacing). The primary end point of the study was the initial occurrence of AF or atrial flutter with a ventricular rate greater than 100 beats per minute for 10 consecutive minutes or completion of the 48-hour monitoring period.</p></sec><sec id="st3"><title>RESULTS</title><p>We evaluated 64 consecutive CABG candidates with sinus rhythm. They were allocated to two groups of ventricular pacing and atrial ventricular pacing (n = 32 in each group). Three patients in the ventricular pacing group (10%) and six in the atrial ventricular pacing group (22%) had sustained AF during the first 48 hours after CABG (P = 0.18 according to Fisher&#x02019;s exact test).</p></sec><sec id="st4"><title>CONCLUSION</title><p>Continuous atrial pacing in the postoperative setting is safe and well-tolerated. In this study, we found that temporary atrial pacing increased the frequency of postoperative AF. Since the difference between the two groups was not significant, larger studies are required to determine the exact relation between pacing method and AF.</p></sec></abstract><kwd-group><kwd>Atrial Fibrillation</kwd><kwd>Coronary Artery Bypass Graft</kwd><kwd>Atrial Pacing</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Atrial fibrillation (AF) after coronary artery bypass graft (CABG) surgery is a common problem.<xref ref-type="bibr" rid="b1-ARYA-09-11">1</xref> It is associated with longer intensive care unit (ICU) and hospital stay and increased costs of postoperative care.<xref ref-type="bibr" rid="b2-ARYA-09-11">2</xref> On the other hand, treatment with electrical cardioversion, antiarrhythmic and anticoagulant drugs adds significant morbidity and cost.<xref ref-type="bibr" rid="b1-ARYA-09-11">1</xref>,<xref ref-type="bibr" rid="b3-ARYA-09-11">3</xref> Prophylactic pharmacological treatment has also been disappointing. Although a recent trial found a significant reduction in postoperative AF after treatment with amiodarone, the incidence of AF in the treatment group was still 25% and concerns about potential morbidity exist.<xref ref-type="bibr" rid="b4-ARYA-09-11">4</xref> Atrial-based pacing has become an attractive non-pharmacological therapy for the prevention of AF.<xref ref-type="bibr" rid="b5-ARYA-09-11">5</xref></p><p>Patients undergoing CABG surgery have temporary atrial and ventricular pacing wires implanted at the time of surgery. Since the incidence of AF is high among these patients, they may provide a model to examine the impact of prophylactic atrial pacing. Such a technique would also be of extreme clinical value in reducing the cost and morbidity associated with postoperative AF. In this study, we sought to evaluate the safety and tolerance of continuous atrial pacing after CABG. We hypothesized that a strategy of temporary atrial pacing after CABG would reduce the incidence of postoperative AF.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><p>During 2012, CABG candidates over 18 years of age at Sina Hospital (Isfahan, Iran) were recruited. All patients had to be in sinus rhythm before surgery and on no antiarrhythmic medications. Before surgery, the participants were randomly assigned to two groups of ventricular pacing and left atrial ventricular pacing (atrial pacing). The subjects were followed for 48 hours after the operation.</p><p>Patients were excluded if they had a known history of AF or atrial flutter requiring antiarrhythmic medications, had renal or hepatic dysfunction (serum creatinine &#x0003e; 3mg/dl, liver enzyme tests &#x0003e; 3 &#x000d7; normalU/L), or were unable to give informed consent. In addition, patients in whom epicardial pacing wires could not be placed during surgery, or patients who developed postoperative ventricular arrhythmias requiring therapy with oral or intravenous antiarrhythmic agents other than intravenous lidocaine were excluded. Patients who required temporary pacing immediately after surgery due to hemodynamic compromise remained in the study. Baseline characteristics and history of arrhythmia were ascertained from direct patient interviews and review of their medical records.</p><p>All patients had one set of ventricular pacing wires (Model #6500, Medtronic Inc., Minneapolis, Minnesota, USA) implanted at the conclusion of surgery. Half of the patients also had atrial wires implanted in the standard location attached to the posterior surface of the left atrium between the right superior and inferior pulmonic veins. The ventricular wires were attached to the right ventricular apex in the standard fashion.</p><p>Patients in the ventricular group were paced using the single-chamber pacing mode at a backup rate of 50 pulses per minute (ppm) in the surgical ICU. Patients in the atrial group were paced with a temporary external dual-chamber pacemaker (Model #5346, Medtronic Inc., Minneapolis, Minnesota, USA) using the atrioventricular (AV) universal (DDD) mode at a lower rate limit of 100 ppm with an AV delay of 220 ms to establish continuous atrial pacing at rest. Pacemaker settings included an upper-rate limit of 140 ppm, a post ventricular atrial refractory period of 175 ms, atrial sensitivity of 0.5 mV, ventricular sensitivity of 2 mV and maximum atrial and ventricular pacing output of 20 mA. Pacing was continued for 48 hours or until the first sustained episode of AF (&#x0003e; 10 minutes).</p><p>After the operation, physicians were instructed to continue beta-adrenergic blocking agents in all patients who had received preoperative beta-blocker therapy. Preoperative beta-blockers were administered through the morning of surgery. Oral metoprolol (25 mg twice daily) was also started postoperatively as soon as all intravenous inotropes were discontinued. The dose was titrated upward at the discretion of the attending surgeon. Patients not on preoperative beta-blockers received these agents in the postoperative period if no contraindications were found.</p><p>Patients were continuously monitored during the study period with a telemetry system. Pacing and sensing thresholds for both atrial and ventricular leads were checked after arrival at the ICU and daily thereafter to ensure the capture. The underlying heart rhythm and rate were documented daily. When considered stable, patients were transferred from the ICU to monitored beds in the general hospital ward where pacing was discontinued.</p><p>The primary end point of the study was the initial occurrence of AF or atrial flutter with a ventricular rate greater than 100 beats per minute for 10 consecutive minutes or completion of the 48-hour monitoring period. An investigator reviewed the hospital chart and full telemetry at least once daily to monitor the cardiac rhythm and establish the time of onset of AF.</p><sec><title>Data analysis</title><p>All values were expressed as mean &#x000b1; standard deviation (SD). Baseline characteristics of the study groups were compared using Student&#x02019;s t-test or analysis of variance for continuous variables and chi-square test for discrete variables. Other tests including Mann-Whitney, Fisher&#x02019;s exact, and Mantel-Haenszel tests were applied for analysis of data. All analyses were performed with SPSS for Windows 20.0 (SPSS Inc., Chicago, IL, USA).</p></sec></sec><sec sec-type="result"><title>Results</title><p>We evaluated 64 consecutive CABG candidates with sinus rhythm. They were assigned to two groups of ventricular pacing and atrial ventricular pacing. (n = 32 in each group). The mean age of the participants was 57.86 &#x000b1; 10.16 years. Independent t-test did not show significant differences in age, LVEF, Hb level, O2 saturation, and Cr level between the two groups (<xref ref-type="table" rid="t1-ARYA-09-11">Table 1</xref>). Moreover, the two groups matched well in terms of gender distribution (P = 0.08 in chi-square test and P = 0.86 in Mantel-Haenszel test).</p><p>Chi-square test did not suggest the two groups to be significantly different in terms of risk factors such as presence of hypertension, pulmonary disease, history of smoking, and diabetes (<xref ref-type="table" rid="t2-ARYA-09-11">Table 2</xref>). None of the patients in either group reported documented lung disease.</p><p>Mann-Whitney test showed that the two groups were matched in regard to angina level (according to the Canadian Cardiovascular Society classification)<xref ref-type="bibr" rid="b6-ARYA-09-11">6</xref> and level of dyspnea (according to New York Heart Association classification)<xref ref-type="bibr" rid="b6-ARYA-09-11">6</xref> (<xref ref-type="table" rid="t3-ARYA-09-11">Table 3</xref>). Three patients in the ventricular pacing group (10%) and six in the atrial ventricular pacing group (22%) had sustained AF during the first 48 hours after CABG (P = 0.18 according to Fisher&#x02019;s exact test).</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Echocardiography recordings during the first 48 hours after CABG showed that AF occurred in 10% of patients with ventricular pacemakers and 22% of those with atrial ventricular pacemakers.</p><p>The pathogenesis of post-CABG AF has been proposed to be multifactorial with abnormal atrial conduction and lack of uniformity of atrial repolarization as main elements. It can have different triggers including premature contractions, pericarditis, electrolyte disorders, cardiopulmonary bypass and cardioplegia.<xref ref-type="bibr" rid="b7-ARYA-09-11">7</xref>,<xref ref-type="bibr" rid="b8-ARYA-09-11">8</xref></p><p>The limited efficacy of conventional agents has led to searches for non-pharmacological modalities for the prevention of postoperative AF. About a decade ago, Coumel<xref ref-type="bibr" rid="b9-ARYA-09-11">9</xref> and Attuel et al.<xref ref-type="bibr" rid="b10-ARYA-09-11">10</xref> were among the first to report the potential of pacing in prevention of AF. They described the use of single-site atrial overdrive pacing to prevent AF or flutter in a selected group of patients with vagally mediated AF or flutter.<xref ref-type="bibr" rid="b9-ARYA-09-11">9</xref>,<xref ref-type="bibr" rid="b10-ARYA-09-11">10</xref> Further studies by Murgatroyd et al. utilized a unique pacing algorithm for the suppression of atrial premature depolarizations.<xref ref-type="bibr" rid="b11-ARYA-09-11">11</xref> This technique resulted in a significant reduction in episodes of AF. The mechanism by which atrial overdrive pacing reduces the occurrence of AF is unclear. However, suppression of atrial premature depolarizations and a reduction in the dispersion of refractoriness have been proposed.<xref ref-type="bibr" rid="b12-ARYA-09-11">12</xref>,<xref ref-type="bibr" rid="b13-ARYA-09-11">13</xref></p><p>Most evidence suggests that AF is a reentrant rhythm consisting of multiple wandering wavelets of electrical activity.<xref ref-type="bibr" rid="b14-ARYA-09-11">14</xref>,<xref ref-type="bibr" rid="b15-ARYA-09-11">15</xref> It is often initiated by atrial premature beats (APB) encountering areas of slow conduction and unidirectional block.<xref ref-type="bibr" rid="b16-ARYA-09-11">16</xref> There are many reasons why one might expect atrial pacing to be effective in preventing AF. Increasing atrial rate suppresses the APB which may initiate AF. A prospective randomized trial found that AF recurrences are reduced in patients receiving right atrial pacing compared to those receiving ventricular pacing.<xref ref-type="bibr" rid="b17-ARYA-09-11">17</xref> Papageorgiou et al. found that the posterior triangle of Koch is a critical area of slow conduction and that coronary sinus (i.e. left atrial) pacing prevented the induction of AF by high right atrial APB.<xref ref-type="bibr" rid="b18-ARYA-09-11">18</xref></p><p>In our study, three patients in the ventricular pacing group (10%) vs. six in the atrial ventricular pacing group (22%) had sustained AF during the first 48 hours after CABG. Although the frequency of AF was higher in the atrial paced group, the difference was not significant. Another study suggested that temporary pacing may paradoxically induce AF in some patients if inappropriate sensing leads to pacing during atrial repolarization.<xref ref-type="bibr" rid="b19-ARYA-09-11">19</xref> While the findings of some studies about the absence of a significant reduction in recurrence of AF using atrial pacing were similar to our observations,<xref ref-type="bibr" rid="b5-ARYA-09-11">5</xref> other researchers have reported favorable effects of right atrial pacing in reducing post-CABG AF.<xref ref-type="bibr" rid="b19-ARYA-09-11">19</xref></p><p>Pacing was well tolerated in all patients and did not increase hospital stay. There were no complications related to the placement of left atrial pacing wires at the conclusion of surgery.</p><p>Among the strengths of our study was eliminating the effects of risk factors associated with frequency of AF. In other words, age, sex, LVEF, Cr level, pulmonary disease, diabetes mellitus, hypertension, anemia, and hypoxia were completely adjusted in the two groups.</p><sec><title>Conclusion</title><p>Continuous atrial pacing in the postoperative setting is safe and well tolerated. In this study, we found that temporary atrial pacing increased the frequency of postoperative AF. Since the difference between the two groups was not significant, larger studies are required to determine the exact relation between pacing method and AF.</p></sec></sec></body><back><fn-group><fn><p>
<bold>Conflicts of Interest</bold>
</p><p>Authors have no conflict of interests.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="b1-ARYA-09-11"><label>1</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aranki</surname><given-names>SF</given-names></name><name><surname>Shaw</surname><given-names>DP</given-names></name><name><surname>Adams</surname><given-names>DH</given-names></name><name><surname>Rizzo</surname><given-names>RJ</given-names></name><name><surname>Couper</surname><given-names>GS</given-names></name><name><surname>VanderVliet</surname><given-names>M</given-names></name><etal/></person-group>
<article-title> Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources.</article-title>
<source>Circulation</source>
<year>1996</year>
<volume>94</volume>
<issue>3</issue>
<fpage>390</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">8759081</pub-id></element-citation></ref><ref id="b2-ARYA-09-11"><label>2</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Crystal</surname><given-names>E</given-names></name><name><surname>Healey</surname><given-names>J</given-names></name><name><surname>Connolly</surname><given-names>SJ</given-names></name></person-group>
<article-title> Atrial fibrillation after cardiac surgery: update on the evidence on the available prophylactic interventions.</article-title>
<source>Card Electrophysiol Rev</source>
<year>2003</year>
<volume>7</volume>
<issue>2</issue>
<fpage>189</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="pmid">14618049</pub-id></element-citation></ref><ref id="b3-ARYA-09-11"><label>3</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mathew</surname><given-names>JP</given-names></name><name><surname>Parks</surname><given-names>R</given-names></name><name><surname>Savino</surname><given-names>JS</given-names></name><name><surname>Friedman</surname><given-names>AS</given-names></name><name><surname>Koch</surname><given-names>C</given-names></name><name><surname>Mangano</surname><given-names>DT</given-names></name><etal/></person-group>
<article-title> Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group.</article-title>
<source>JAMA</source>
<year>1996</year>
<volume>276</volume>
<issue>4</issue>
<fpage>300</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">8656542</pub-id></element-citation></ref><ref id="b4-ARYA-09-11"><label>4</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Daoud</surname><given-names>EG</given-names></name><name><surname>Strickberger</surname><given-names>SA</given-names></name><name><surname>Man</surname><given-names>KC</given-names></name><name><surname>Goyal</surname><given-names>R</given-names></name><name><surname>Deeb</surname><given-names>GM</given-names></name><name><surname>Bolling</surname><given-names>SF</given-names></name><etal/></person-group>
<article-title> Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery.</article-title>
<source>N Engl J Med</source>
<year>1997</year>
<volume>337</volume>
<issue>25</issue>
<fpage>1785</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="pmid">9400034</pub-id></element-citation></ref><ref id="b5-ARYA-09-11"><label>5</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gerstenfeld</surname><given-names>EP</given-names></name><name><surname>Hill</surname><given-names>MR</given-names></name><name><surname>French</surname><given-names>SN</given-names></name><name><surname>Mehra</surname><given-names>R</given-names></name><name><surname>Rofino</surname><given-names>K</given-names></name><name><surname>Vander Salm</surname><given-names>TJ</given-names></name><etal/></person-group>
<article-title> Evaluation of right atrial and biatrial temporary pacing for the prevention of atrial fibrillation after coronary artery bypass surgery.</article-title>
<source>J Am Coll Cardiol</source>
<year>1999</year>
<volume>33</volume>
<issue>7</issue>
<fpage>1981</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">10362203</pub-id></element-citation></ref><ref id="b6-ARYA-09-11"><label>6</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Bonow</surname><given-names>RO</given-names></name><name><surname>Mann</surname><given-names>DL</given-names></name><name><surname>Zipes</surname><given-names>DP</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name></person-group>
<source>Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.</source>
<publisher-loc>Philadelphia, PA</publisher-loc>
<publisher-name>Elsevier Health Sciences</publisher-name>
<year>2011</year>
<fpage>108</fpage>
</element-citation></ref><ref id="b7-ARYA-09-11"><label>7</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cooklin</surname><given-names>M</given-names></name><name><surname>Gold</surname><given-names>MR</given-names></name></person-group>
<article-title> Implications and treatment of atrial fibrillation after cardiothoracic surgery.</article-title>
<source>Curr Opin Cardiol</source>
<year>1998</year>
<volume>13</volume>
<issue>1</issue>
<fpage>20</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">9559253</pub-id></element-citation></ref><ref id="b8-ARYA-09-11"><label>8</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mohr</surname><given-names>R</given-names></name><name><surname>Smolinsky</surname><given-names>A</given-names></name><name><surname>Goor</surname><given-names>DA</given-names></name></person-group>
<article-title> Prevention of supraventricular tachyarrhythmia with low-dose propranolol after coronary bypass.</article-title>
<source>J Thorac Cardiovasc Surg</source>
<year>1981</year>
<volume>81</volume>
<issue>6</issue>
<fpage>840</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">7015021</pub-id></element-citation></ref><ref id="b9-ARYA-09-11"><label>9</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coumel</surname><given-names>P</given-names></name></person-group>
<article-title> Paroxysmal atrial fibrillation: a disorder of autonomic tone?</article-title>
<source>Eur Heart J</source>
<year>1994</year>
<volume>15 (Suppl A)</volume>
<fpage>9</fpage>
<pub-id pub-id-type="pmid">8070496</pub-id></element-citation></ref><ref id="b10-ARYA-09-11"><label>10</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Attuel</surname><given-names>P</given-names></name><name><surname>Pellerin</surname><given-names>D</given-names></name><name><surname>Mugica</surname><given-names>J</given-names></name><name><surname>Coumel</surname><given-names>P</given-names></name></person-group>
<article-title> DDD pacing: an effective treatment modality for recurrent atrial arrhythmias.</article-title>
<source>Pacing Clin Electrophysiol</source>
<year>1988</year>
<volume>11</volume>
<issue>11 Pt 2</issue>
<fpage>1647</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="pmid">2463527</pub-id></element-citation></ref><ref id="b11-ARYA-09-11"><label>11</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Murgatroyd</surname><given-names>FD</given-names></name><name><surname>Nitzsche</surname><given-names>R</given-names></name><name><surname>Slade</surname><given-names>AK</given-names></name><name><surname>Limousin</surname><given-names>M</given-names></name><name><surname>Rosset</surname><given-names>N</given-names></name><name><surname>Camm</surname><given-names>AJ</given-names></name><etal/></person-group>
<article-title> A new pacing algorithm for overdrive suppression of atrial fibrillation. Chorus Multicentre Study Group.</article-title>
<source>Pacing Clin Electrophysiol</source>
<year>1994</year>
<volume>17</volume>
<issue>11 Pt 2</issue>
<fpage>1966</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="pmid">7845800</pub-id></element-citation></ref><ref id="b12-ARYA-09-11"><label>12</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ramdat</surname><given-names>MA</given-names></name><name><surname>Beukema</surname><given-names>WP</given-names></name><name><surname>Oude Luttikhuis</surname><given-names>HA</given-names></name></person-group>
<article-title> Multisite or alternate site pacing for the prevention of atrial fibrillation.</article-title>
<source>Am J Cardiol</source>
<year>1999</year>
<volume>83</volume>
<issue>5B</issue>
<fpage>237D</fpage>
<lpage>40D</lpage>
</element-citation></ref><ref id="b13-ARYA-09-11"><label>13</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luck</surname><given-names>JC</given-names></name><name><surname>Engel</surname><given-names>TR</given-names></name></person-group>
<article-title> Dispersion of atrial refractoriness in patients with sinus node dysfunction.</article-title>
<source>Circulation</source>
<year>1979</year>
<volume>60</volume>
<issue>2</issue>
<fpage>404</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">87283</pub-id></element-citation></ref><ref id="b14-ARYA-09-11"><label>14</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moe</surname><given-names>GK</given-names></name></person-group>
<article-title> On the multiple wavelet hypothesis of atrial fibrillation.</article-title>
<source>Arch Int Pharmacodyn</source>
<year>1962</year>
<volume>140</volume>
<fpage>183</fpage>
<lpage>7</lpage>
</element-citation></ref><ref id="b15-ARYA-09-11"><label>15</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Allesie</surname><given-names>MA</given-names></name><name><surname>Lammers</surname><given-names>WJ</given-names></name><name><surname>Bonke</surname><given-names>FI</given-names></name><name><surname>Hollen</surname><given-names>J</given-names></name></person-group>
<article-title> Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation.</article-title>
<person-group person-group-type="editor"><name><surname>Zipes</surname><given-names>DP</given-names></name><name><surname>Jalife</surname><given-names>J</given-names></name></person-group>
<source>Cardiac electrophysiology and arrhythmias.</source>
<publisher-loc>Orlando, FL</publisher-loc>
<publisher-name>Grune &#x00026; Stratton</publisher-name>
<year>1985</year>
<fpage>265</fpage>
<lpage>75</lpage>
</element-citation></ref><ref id="b16-ARYA-09-11"><label>16</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Papageorgiou</surname><given-names>P</given-names></name><name><surname>Monahan</surname><given-names>K</given-names></name><name><surname>Boyle</surname><given-names>NG</given-names></name><name><surname>Seifert</surname><given-names>MJ</given-names></name><name><surname>Beswick</surname><given-names>P</given-names></name><name><surname>Zebede</surname><given-names>J</given-names></name><etal/></person-group>
<article-title> Site-dependent intra-atrial conduction delay. Relationship to initiation of atrial fibrillation.</article-title>
<source>Circulation</source>
<year>1996</year>
<volume>94</volume>
<issue>3</issue>
<fpage>384</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">8759080</pub-id></element-citation></ref><ref id="b17-ARYA-09-11"><label>17</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andersen</surname><given-names>HR</given-names></name><name><surname>Nielsen</surname><given-names>JC</given-names></name><name><surname>Thomsen</surname><given-names>PE</given-names></name><name><surname>Thuesen</surname><given-names>L</given-names></name><name><surname>Mortensen</surname><given-names>PT</given-names></name><name><surname>Vesterlund</surname><given-names>T</given-names></name><etal/></person-group>
<article-title> Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome.</article-title>
<source>Lancet</source>
<year>1997</year>
<volume>350</volume>
<issue>9086</issue>
<fpage>1210</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">9652562</pub-id></element-citation></ref><ref id="b18-ARYA-09-11"><label>18</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Papageorgiou</surname><given-names>P</given-names></name><name><surname>Anselme</surname><given-names>F</given-names></name><name><surname>Kirchhof</surname><given-names>CJ</given-names></name><name><surname>Monahan</surname><given-names>K</given-names></name><name><surname>Rasmussen</surname><given-names>CA</given-names></name><name><surname>Epstein</surname><given-names>LM</given-names></name><etal/></person-group>
<article-title> Coronary sinus pacing prevents induction of atrial fibrillation.</article-title>
<source>Circulation</source>
<year>1997</year>
<volume>96</volume>
<issue>6</issue>
<fpage>1893</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">9323078</pub-id></element-citation></ref><ref id="b19-ARYA-09-11"><label>19</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Greenberg</surname><given-names>MD</given-names></name><name><surname>Katz</surname><given-names>NM</given-names></name><name><surname>Iuliano</surname><given-names>S</given-names></name><name><surname>Tempesta</surname><given-names>BJ</given-names></name><name><surname>Solomon</surname><given-names>AJ</given-names></name></person-group>
<article-title> Atrial pacing for the prevention of atrial fibrillation after cardiovascular surgery.</article-title>
<source>J Am Coll Cardiol</source>
<year>2000</year>
<volume>35</volume>
<issue>6</issue>
<fpage>1416</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="pmid">10807441</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="t1-ARYA-09-11" position="float"><label>Table 1</label><caption><p>Description of quantitative variables</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">
Variable</th><th colspan="3" align="center" rowspan="1">
Atrial ventricularpacing<hr/></th><th colspan="3" align="center" rowspan="1">
Ventricular pacing<hr/></th><th rowspan="2" align="center" colspan="1">
P</th></tr><tr><th align="center" rowspan="1" colspan="1">
Minimum</th><th align="center" rowspan="1" colspan="1">
Maximum</th><th align="center" rowspan="1" colspan="1">
Mean &#x000b1; SD</th><th align="center" rowspan="1" colspan="1">
Minimum</th><th align="center" rowspan="1" colspan="1">
Maximum</th><th align="center" rowspan="1" colspan="1">
Mean &#x000b1; SD</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
Age</td><td align="center" rowspan="1" colspan="1">
36.00</td><td align="center" rowspan="1" colspan="1">
75.00</td><td align="center" rowspan="1" colspan="1">
57.85 &#x000b1; 9.82</td><td align="center" rowspan="1" colspan="1">
28.00</td><td align="center" rowspan="1" colspan="1">
78.00</td><td align="center" rowspan="1" colspan="1">
57.87 &#x000b1; 10.63</td><td align="center" rowspan="1" colspan="1">
0.99</td></tr><tr><td rowspan="1" colspan="1">
Creatinine</td><td align="center" rowspan="1" colspan="1">
2.00</td><td align="center" rowspan="1" colspan="1">
0.70</td><td align="center" rowspan="1" colspan="1">
1.01 &#x000b1; 0.28</td><td align="center" rowspan="1" colspan="1">
3.00</td><td align="center" rowspan="1" colspan="1">
0.70</td><td align="center" rowspan="1" colspan="1">
1.03 &#x000b1; 0.44</td><td align="center" rowspan="1" colspan="1">
0.81</td></tr><tr><td rowspan="1" colspan="1">
Oxygen saturation</td><td align="center" rowspan="1" colspan="1">
95.00</td><td align="center" rowspan="1" colspan="1">
99.70</td><td align="center" rowspan="1" colspan="1">
98.40 &#x000b1; 0.60</td><td align="center" rowspan="1" colspan="1">
94.00</td><td align="center" rowspan="1" colspan="1">
100.00</td><td align="center" rowspan="1" colspan="1">
98.24 &#x000b1; 0.96</td><td align="center" rowspan="1" colspan="1">
0.48</td></tr><tr><td rowspan="1" colspan="1">
Leftventricular ejection fraction</td><td align="center" rowspan="1" colspan="1">
20.00</td><td align="center" rowspan="1" colspan="1">
65.00</td><td align="center" rowspan="1" colspan="1">
51.66 &#x000b1; 11.00</td><td align="center" rowspan="1" colspan="1">
60.00</td><td align="center" rowspan="1" colspan="1">
25.00</td><td align="center" rowspan="1" colspan="1">
49.80 &#x000b1; 10.70</td><td align="center" rowspan="1" colspan="1">
0.92</td></tr><tr><td rowspan="1" colspan="1">
Hemoglobin</td><td align="center" rowspan="1" colspan="1">
12.00</td><td align="center" rowspan="1" colspan="1">
16.00</td><td align="center" rowspan="1" colspan="1">
13.19 &#x000b1; 2.60</td><td align="center" rowspan="1" colspan="1">
9.90</td><td align="center" rowspan="1" colspan="1">
15.30</td><td align="center" rowspan="1" colspan="1">
13.16 &#x000b1; 1.20</td><td align="center" rowspan="1" colspan="1">
0.95</td></tr></tbody></table></table-wrap><table-wrap id="t2-ARYA-09-11" position="float"><label>Table 2</label><caption><p>Description of qualitative variabes</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" rowspan="1">
</th><th rowspan="1" colspan="1">
Atrial pacing group (%)</th><th rowspan="1" colspan="1">
Atrial ventricularpacing group (%)</th><th rowspan="1" colspan="1">
P</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
Gender</td><td align="center" rowspan="1" colspan="1">
Male</td><td align="center" rowspan="1" colspan="1">
88.9</td><td align="center" rowspan="1" colspan="1">
70.0</td><td align="center" rowspan="2" colspan="1">
0.08</td></tr><tr><td rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">
Female</td><td align="center" rowspan="1" colspan="1">
11.1</td><td align="center" rowspan="1" colspan="1">
30.0</td></tr><tr><td rowspan="1" colspan="1">
Hypertension</td><td align="center" rowspan="1" colspan="1">
No</td><td align="center" rowspan="1" colspan="1">
59.3</td><td align="center" rowspan="1" colspan="1">
53.3</td><td align="center" rowspan="3" colspan="1">
0.23</td></tr><tr><td rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">
Not known</td><td align="center" rowspan="1" colspan="1">
3.7</td><td align="center" rowspan="1" colspan="1">
3.3</td></tr><tr><td rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">
Treated</td><td align="center" rowspan="1" colspan="1">
37.0</td><td align="center" rowspan="1" colspan="1">
43.3</td></tr><tr><td rowspan="1" colspan="1">
Smoking history</td><td align="center" rowspan="1" colspan="1">
Never</td><td align="center" rowspan="1" colspan="1">
77.8</td><td align="center" rowspan="1" colspan="1">
79.3</td><td align="center" rowspan="3" colspan="1">
0.83</td></tr><tr><td rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">
Ex-smoker</td><td align="center" rowspan="1" colspan="1">
11.1</td><td align="center" rowspan="1" colspan="1">
6.9</td></tr><tr><td rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">
Smoker</td><td align="center" rowspan="1" colspan="1">
11.1</td><td align="center" rowspan="1" colspan="1">
13.8</td></tr><tr><td rowspan="1" colspan="1">
Diabetes</td><td align="center" rowspan="1" colspan="1">
No</td><td align="center" rowspan="1" colspan="1">
63.0</td><td align="center" rowspan="1" colspan="1">
70.0</td><td align="center" rowspan="4" colspan="1">
0.57</td></tr><tr><td rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">
On diet</td><td align="center" rowspan="1" colspan="1">
3.7</td><td align="center" rowspan="1" colspan="1">
0</td></tr><tr><td rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">
On oral agent</td><td align="center" rowspan="1" colspan="1">
33.3</td><td align="center" rowspan="1" colspan="1">
26.7</td></tr><tr><td rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">
On insulin+oral agent</td><td align="center" rowspan="1" colspan="1">
0</td><td align="center" rowspan="1" colspan="1">
3.3</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-ARYA-09-11"><p>Values are expressed as percentages.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-ARYA-09-11" position="float"><label>Table 3</label><caption><p>Description od Angina and Dyspnea in Atrial And Ventricular Pacing groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" rowspan="1">
</th><th align="center" rowspan="1" colspan="1">
Atrial ventricular pacinggroup (%)</th><th align="center" rowspan="1" colspan="1">
Ventricular pacing group(%)</th><th align="center" rowspan="1" colspan="1">
P</th></tr></thead><tbody><tr><td rowspan="4" colspan="1">
Angina<xref rid="tfn2-ARYA-09-11" ref-type="table-fn">*</xref></td><td rowspan="1" colspan="1">
1</td><td align="center" rowspan="1" colspan="1">
3.7</td><td align="center" rowspan="1" colspan="1">
6.7</td><td align="center" rowspan="4" colspan="1">
0.44</td></tr><tr><td rowspan="1" colspan="1">
2</td><td align="center" rowspan="1" colspan="1">
85.2</td><td align="center" rowspan="1" colspan="1">
86.7</td></tr><tr><td rowspan="1" colspan="1">
3</td><td align="center" rowspan="1" colspan="1">
7.4</td><td align="center" rowspan="1" colspan="1">
6.7</td></tr><tr><td rowspan="1" colspan="1">
4</td><td align="center" rowspan="1" colspan="1">
3.7</td><td align="center" rowspan="1" colspan="1">
0</td></tr><tr><td rowspan="4" colspan="1">
Dyspnea<xref rid="tfn2-ARYA-09-11" ref-type="table-fn">**</xref></td><td rowspan="1" colspan="1">
1</td><td align="center" rowspan="1" colspan="1">
7.4</td><td align="center" rowspan="1" colspan="1">
6.7</td><td align="center" rowspan="4" colspan="1">
0.91</td></tr><tr><td rowspan="1" colspan="1">
2</td><td align="center" rowspan="1" colspan="1">
92.6</td><td align="center" rowspan="1" colspan="1">
93.3</td></tr><tr><td rowspan="1" colspan="1">
3</td><td align="center" rowspan="1" colspan="1">
0</td><td align="center" rowspan="1" colspan="1">
0</td></tr><tr><td rowspan="1" colspan="1">
4</td><td align="center" rowspan="1" colspan="1">
0</td><td align="center" rowspan="1" colspan="1">
0</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-ARYA-09-11"><label>*</label><p>Canadian Cardiovascular Society classification</p></fn><fn id="tfn3-ARYA-09-11"><label>**</label><p>New York Heart Association classification</p></fn></table-wrap-foot></table-wrap></floats-group></article>